Herbalife Nutrition Ltd (NYSE:HLF) was the recipient of a significant increase in short interest in May. As of May 15th, there was short interest totalling 12,885,352 shares, an increase of 99.6% from the April 30th total of 6,454,575 shares. Based on an average daily trading volume, of 1,724,503 shares, the short-interest ratio is currently 7.5 days. Approximately 8.2% of the company’s stock are sold short.
HLF stock traded up $0.80 during midday trading on Thursday, reaching $54.00. 1,076,496 shares of the company’s stock traded hands, compared to its average volume of 2,383,904. Herbalife Nutrition has a 52-week low of $30.35 and a 52-week high of $56.74. The stock has a market cap of $9.37 billion, a P/E ratio of 22.22 and a beta of 1.13. The company has a current ratio of 2.14, a quick ratio of 1.78 and a debt-to-equity ratio of -9.63.
Herbalife Nutrition (NYSE:HLF) last announced its earnings results on Thursday, May 3rd. The company reported $0.70 EPS for the quarter, beating the Zacks’ consensus estimate of $0.56 by $0.14. The business had revenue of $1.18 billion during the quarter, compared to analysts’ expectations of $1.12 billion. Herbalife Nutrition had a net margin of 4.68% and a negative return on equity of 1,193.47%. The firm’s revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the company earned $0.62 earnings per share. equities analysts forecast that Herbalife Nutrition will post 2.67 earnings per share for the current year.
In related news, EVP Alan L. Hoffman sold 26,157 shares of the stock in a transaction that occurred on Monday, May 7th. The shares were sold at an average price of $112.96, for a total transaction of $2,954,694.72. Following the transaction, the executive vice president now owns 1,882 shares in the company, valued at $212,590.72. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, major shareholder Carl C. Icahn sold 10,516,744 shares of the stock in a transaction that occurred on Wednesday, May 30th. The shares were sold at an average price of $52.50, for a total transaction of $552,129,060.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 10,574,626 shares of company stock worth $557,289,860. Insiders own 6.19% of the company’s stock.
Hedge funds and other institutional investors have recently made changes to their positions in the company. American International Group Inc. purchased a new stake in shares of Herbalife Nutrition in the fourth quarter worth $103,000. BNP Paribas Arbitrage SA increased its stake in shares of Herbalife Nutrition by 124.4% in the first quarter. BNP Paribas Arbitrage SA now owns 1,462 shares of the company’s stock worth $143,000 after purchasing an additional 7,461 shares in the last quarter. Barings LLC purchased a new stake in shares of Herbalife Nutrition in the first quarter worth $203,000. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Herbalife Nutrition by 36.5% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,445 shares of the company’s stock worth $233,000 after purchasing an additional 922 shares in the last quarter. Finally, Macquarie Group Ltd. purchased a new stake in shares of Herbalife Nutrition in the fourth quarter worth $291,000. 45.51% of the stock is owned by hedge funds and other institutional investors.
A number of research analysts recently weighed in on the stock. Longbow Research increased their price objective on shares of Herbalife Nutrition from $47.14 to $57.00 and gave the company a “buy” rating in a research report on Tuesday, March 6th. TheStreet downgraded shares of Herbalife Nutrition from a “b-” rating to a “c” rating in a research report on Monday, March 5th. Zacks Investment Research upgraded shares of Herbalife Nutrition from a “hold” rating to a “buy” rating and set a $54.00 price objective on the stock in a research report on Thursday, March 8th. ValuEngine downgraded shares of Herbalife Nutrition from a “hold” rating to a “sell” rating in a research report on Wednesday, May 16th. Finally, Citigroup restated a “neutral” rating and set a $42.50 price objective (up previously from $36.50) on shares of Herbalife Nutrition in a research report on Thursday, February 22nd. Three equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $58.00.
About Herbalife Nutrition
Herbalife Nutrition Ltd. develops and sells nutrition solutions in North America, Mexico, South and Central America, Europe, the Middle East, Africa, and the Asia Pacific. It provides science-based products in the areas of weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition.
Receive News & Ratings for Herbalife Nutrition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife Nutrition and related companies with MarketBeat.com's FREE daily email newsletter.